Blog
Theranostics: Combining Diagnostic Imaging and Targeted Treatment
Modern medicine is moving beyond treating every patient with the same standardized approach. One of the most promising examples is theranostics, a precision-medicine strategy that combines diagnostic testing with targeted treatment.
The term blends two words: therapeutics and diagnostics. In nuclear medicine, theranostics typically uses two closely related radiopharmaceuticals. One is designed to locate and image a specific biological target, while the other delivers radiation directly to cells
…
Aug 3rd 2026
Mapping the Next Frontier of Immunotherapy: QSIT Expands Its Scientific Intelligence Program
Truway Health has expanded the scientific-intelligence framework supporting the Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study, identified as TWH-QSIT-IMMUNENET-2025-01 and NCT07221565.
The July 19, 2026 PubMed Intelligence Sweep broadens the study’s continuous monitoring across immunology, cellular metabolism, genetic engineering, cancer genomics, pharmacokinetics, pharmacovigilance, and international research governance.
Connecting Immune Signaling, Energy, and Geno
…
Jul 19th 2026
Truway Health Advances Long COVID Research with GenBank Submission Linked to NCBI BioProject PRJNA1476232
FOR IMMEDIATE RELEASE ONLY
June 10, 2026
Truway Health, Inc. announced the submission of genomic sequence records to the National Center for Biotechnology Information (NCBI) GenBank database under Submission SUB16248244, representing a significant advancement in the company's Long COVID host genomics research program.
The submission is linked to the previously established BioProject PRJNA1476232, entitled Truway Health Long COVID Cohort Host Genomics Study, and integrates accessioned BioSample a
…
Jun 10th 2026